Procedure versus process: ethical paradigms and the conduct of qualitative research by Kristian Pollock
Pollock BMC Medical Ethics 2012, 13:25
http://www.biomedcentral.com/1472-6939/13/25DEBATE Open AccessProcedure versus process: ethical paradigms and
the conduct of qualitative research
Kristian PollockAbstract
Background: Research is fundamental to improving the quality of health care. The need for regulation of research
is clear. However, the bureaucratic complexity of research governance has raised concerns that the regulatory
mechanisms intended to protect participants now threaten to undermine or stifle the research enterprise, especially
as this relates to sensitive topics and hard to reach groups.
Discussion: Much criticism of research governance has focused on long delays in obtaining ethical approvals,
restrictions imposed on study conduct, and the inappropriateness of evaluating qualitative studies within the
methodological and risk assessment frameworks applied to biomedical and clinical research. Less attention has
been given to the different epistemologies underlying biomedical and qualitative investigation. The bioethical
framework underpinning current regulatory structures is fundamentally at odds with the practice of emergent,
negotiated micro-ethics required in qualitative research. The complex and shifting nature of real world settings
delivers unanticipated ethical issues and (occasionally) genuine dilemmas which go beyond easy or formulaic
‘procedural’ resolution. This is not to say that qualitative studies are ‘unethical’ but that their ethical nature can only
be safeguarded through the practice of ‘micro-ethics’ based on the judgement and integrity of researchers in the
field.
Summary: This paper considers the implications of contrasting ethical paradigms for the conduct of qualitative
research and the value of ‘empirical ethics’ as a means of liberating qualitative (and other) research from an
outmoded and unduly restrictive research governance framework based on abstract prinicipalism, divorced from
real world contexts and values.
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At a time when research is promoted as a core activity
within national health care systems, it is ironic that the
bureaucratic complexity of research governance in the
United Kingdom and other developed nations has
increased to a point where the regulatory mechanisms
intended to protect participants now threaten to under-
mine and even stifle the research enterprise, especially
as this relates to sensitive issues and hard to reach
groups. Concerns are mounting that such mechanisms
increase the cost, reduce the quality and restrict the
scope of research, especially among vulnerable sections
of the population who stand to benefit most from theCorrespondence: kristian.pollock@nottingham.ac.uk
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reproduction in any medium, provided the oroutcome, e.g. older patients and those with dementia, or
who are dying. Far from promoting ethical research and
protecting research subjects from harm, it is argued that
current governance regulations and procedures can ac-
tually work against, and undermine, these goals [1-13]. It
is further argued that research governance has become
onerous to the point of driving research, especially in-
volving pharmaceutical trials, abroad and to areas where
research participants may not be adequately protected
by regulatory structures and processes [3,14,15]. In rela-
tion to qualitative and health services research there is
concern that researchers are being deterred from under-
taking studies involving sensitive topics and vulnerable
populations. As a result research questions are being
censored, methods skewed and questions abandoned as
a result of the real and anticipated difficulties of securing
research governance approvals [8,16-19].his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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obstacle of research governance concerns the long delays
involved in obtaining research approvals and the bureau-
cratic restrictions imposed on the conduct of studies
[14,15,20,21]. This is particularly burdensome for the
substantial and diverse body of research (including
qualitative studies and much health service research)
which does not involve random control trials (RCTs) or
other experimental investigations for which the current
regulatory system is principally designed [9,22]. Some-
what paradoxically, recognition of the value of qualita-
tive methodologies in health services research [23-27]
parallels the evolution of research governance frame-
works which have increasingly constrained their practice.
It is argued that although the risks and potential harms
of qualitative research are minimal compared to experi-
mental or drugs trials, all studies have been subject to
review within the methodological and risk assessment
frameworks applied to biomedical and clinical research
[4,9,22,28-31]. The need to streamline processes of eth-
ical regulation and review of research has been recog-
nised and processes of consultation and reform are
currently in process in countries across Europe, America
and Australia [12,32-35] In the UK the Health Research
Agency (HRA) was established in 2011 to expedite this
process [36-38]. These developments are very welcome.
However, simply streamlining the process of ethical re-
view will not solve the problems arising from 1. (unin-
tended) consequences of the legislative frameworks
within which Research Ethics Committees and Institu-
tional Review Boards operate [6,39]a; and 2. a basic
incompatibility between the dominant bioethical frame-
work which underpins the regulatory structures of re-
search ethics and governance and the principles and
practice intrinsic to qualitative researchb [4,9,22,29,30,
40-45]. Less attention has been paid to the issues deriv-
ing from the different epistemologies which characterize
biomedical and qualitative investigations and their impli-
cations for conducting research in naturalistic, real world
settings. This paper considers the implications of current
legal constraints alongside contrasting ethical paradigms
for the conduct of qualitative research, particularly in
sensitive and difficult areas such as palliative and end of
life care, for which such methods of investigation are par-
ticularly suitable and the need for further research is
pressing.
Discussion
Concerns about the ethical conduct of research are not a
modern preoccupation. Debates within academic disci-
plines such as anthropology and psychology are long-
standing [44]. However, as the bioethical framework
underpinning current regulatory structures of ‘proced-
ural ethics’ has achieved dominance within the changinglegal and political contexts in which research is under-
taken, concerns and practices particular to these other
disciplines have been superseded and overwritten. In-
ternal regulation of research governance has been
replaced by increasingly centralized control [46]. Similar
processes and regulatory structures have developed
across Europe, the US, Canada and Australia. Funding
and sponsorship of health and, increasingly, social re-
search is dependent on receipt of a ‘favourable opinion’
from an accredited review body (Research Ethics
Committee (REC) or Institutional Review Board (IRB))
[47].
Bioethics
Common (and conflicting) principles underlie the pro-
cedurally based bioethical framework characteristic of
the systems of ethical appraisal in the UK and elsewhere:
1. autonomy, 2. beneficence (and non-maleficence) and
3. justice [48]. Respect for autonomy requires that re-
search participation must be voluntary and based on
fully informed consent, with the right to withdraw at any
time. The principle of beneficence/non-maleficence sti-
pulates that research should produce recognizable bene-
fit for both the individuals involved and also the wider
community. It should also cause no harm. This extends
to the protection of individual privacy and identity
through the assurance of confidentiality and anonymity.
Justice involves a commitment to the burdens and bene-
fits of research being shared equally throughout all
populations and sections of society. It also contains the
idea that no section of the population should be
excluded from the opportunity to take part in research
[49]. The problem is not so much with the principles
themselves, but the rigid and formulaic manner of their
application within highly bureaucratic and rule based
systems of ethical review. In addition, rather than retain-
ing an acknowledgement that the four principles are
equal and that balancing may be required where inter-
ests conflict [50], autonomy has acquired a uniquely pri-
vileged position. This reflects the dominant Western
conceptualization of the ‘individual’ as a discrete, self-
governing agent (consumer) [42,43,51,52].
The contingent nature of ethical regulation
Discourses involving ethics invoke transcendent values
and absolute principles. However, as evidenced by the
proliferation, revision and debates regarding codes and
standards the ‘ethical’ frameworks currently regulating
research are contingent cultural constructs: the product
of particular time, place and competing interests
[44,53,54]. Even within the time frame through which
current Western bioethics has developed post World
War Two, sensibilities have altered in relation to accept-
able methods and topics of research and undoubtedly
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of the Nazi regime occurred within a system of regulated
research [4,16,54], while the elaboration of guidelines for
ethical research has not prevented continuing abuse or
mishap, albeit as a (hopefully) infrequent occurrence
[55,56]. We look askance at studies undertaken by some
previous investigators from the 1960s and 1970s [57-61]
through to the present day [62]. Debates continue over
ethically acceptable research design and practice among
predominantly disadvantaged and impoverished popula-
tions of Third World and developing nations [63-66].
The current preoccupation with protection of privacy
and the necessity of informed consent dates only from
the 1990s [45]. It is evident that similar processes and
regulations for ethical review do not produce consistent
outcomes, either within or between countries as closely
related as members of the European Union [67-70]. In
addition, ‘ethical’ principles are interpreted and applied
selectively. The principles of the Helsinki Declaration
regarding the ethical involvement of human participants
in clinical and biomedical research are binding on physi-
cians and should supersede local and national regula-
tions. They supposedly underpin all disciplinary and
national research ethical guidelines. However, where
conflicting interests arise, as in relation to use of place-
bos in clinical trials and the conduct of research in
countries within the developing world, subsequent revi-
sions of the Declaration have been rejected or omitted
by powerful agencies such as the United States Food and
Drug Adminstration ( since 2004) and within regulatory
frameworks including the European Clinical Trials Dir-
ective and the International Conference on Harmonisa-
tion of Good Clinical Practice [65,71-74] .
The case for proportionality
The principle that research should be subject to ethical
review and regulation is not at issue. However, it is rea-
sonable that the mechanisms involved should be
constructive and proportionate [2-4,13,19,29,75,76]. Bio-
medical research has the potential to cause harm to
participants through known or unanticipated risks of
treatment interventions. Bioethical codes are predicated
on assumptions of mistrust and hazard: patients need to
be protected from risky research which is often linked to
powerful commercial interests. Researchers are deemed
to require regulation in order to behave ethically [44]. In
contrast, the risks of qualitative research are minimal,
commensurate with those encountered in everyday life
[4,47]. An abiding principal of ethical research in an-
thropology and other social sciences has been the
researchers’ concern and commitment to protect the
interests of their respondents. In this context it is the
vested interests of powerful commercial and government
agencies, not the researcher, that are perceived toconstitute the source of potential harm [9,44,46]. The
conduct of qualitative health services research has rarely,
if ever, been the subject of demonstrable harm or even
complaint [4,31]. Indeed, there is evidence that those
who take part in qualitative studies often find this to be
a positive experience, and are willing to engage in re-
search even when it involves discussion of topics and
experiences which they anticipate to be distressing and
emotionally challenging. Motivations for such parti-
cipation may be various and complex. They include
curiosity, interest, helpfulness, a chance to receive ac-
knowledgement and reflect on powerful personal
experiences and perhaps the possibility of personal
benefit from research outcomes and findings. How-
ever, a commonly stated motive is altruism, a desire
to ‘give back’ and to contribute to work which may
benefit others and make a contribution to the wider
social good [5,77-94].
Micro ethics and qualitative research
The bioethical framework of procedural ethics is based
on a principle led form of reductive and deductive rea-
soning which lacks social salience and does not relate to
the exigencies of research in real world settings
[9,22,29,30,41,42,45,85,95,96]. Corrigan [43] characteri-
zes the outcome of such procedures as ‘empty ethics’.
Judgements are based on abstract principles and formu-
laic rules without knowledge or consideration of context,
and in accordance with misplaced assumptions which
idealise and reify the process of obtaining informed con-
sent as a ‘rational-technical’ procedure involving ‘fully
informed’ and ‘autonomous’ individuals. Information
sheets and signed consent forms are widely unread and
provide no evidence that respondents have a sufficient
understanding of the research they have been invited to
take part in; they merely confirm that due process has
been observed [85,89]. Indeed, studies of trial partici-
pants indicate that respondents’ knowledge and aware-
ness of the nature and purpose of the study is frequently
poor [97-99]. A more appropriate approach to protect-
ing the ethical integrity of qualitative research is through
recognition of the distinctive epistemological and meth-
odological paradigms involved [30,43,44]. These call for
the application of ‘micro’ or ’process’ rather than ‘pro-
cedural’ ethics [22,95].
Micro ethics is based on judgement rather than rules,
and relies on the cultivation of ‘ethical mindfulness’ on
the part of individual researchers. It involves participa-
tion of research participants on the basis of trust and
motivation during which consent is confirmed as an on-
going process and validated by continuing involvement
[43,88,100,101]. Qualitative research depends not just on
the willing cooperation of respondents, but on their en-
gagement and collaborative input: it is in the process of
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‘data’ are generated and the research can be accom-
plished [18,29,42,44,102-104]. The researcher connects
with participants, on the basis of reciprocal exchange,
through a personal rather than a contractual relation-
ship, and within a relatively even social field [16,105].
The participant needs to get something positive out of
the encounter to sustain continuing involvement. This
in itself requires that participants are given courtesy and
consideration. Since qualitative research rarely involves
intervention, research participants are unlikely to feel
beholden to the investigator, especially where these are
not involved in providing clinical care. In qualitative re-
search participants are constructed as active agents, ra-
ther than passive subjects, who bring their own agenda
to the encounter, and critically appraise their research
experience and involvement. That this may be on the
basis of entirely different criteria than those contained
within the procedural ethics framework does not mean
that their participation is based on bad or unsatisfactory
decisions [85,89].
Issues arise because good and innovative qualitative re-
search cannot be squeezed within the constricting frame
of bioethics c. By its nature, qualitative research is flex-
ible, emergent and negotiated: the direction of enquiry
and even the research question cannot be precisely
anticipated in advance, and may alter in response to
emerging findings [16,18,29,42,83,102,106]. This is par-
ticularly true in relation to ethnographic observation.
Long recognized as the gold standard of qualitative re-
search methods, observation has once more come in
vogue as a powerful method of exploring naturalistic, real
world settings, especially in relation to sensitive topics or
with hard to reach and vulnerable populations. However,
certain features of qualitative work, including ethnog-
raphy, conflict directly with the current principles of bio-
ethics which govern medical and health services
research.
Recruitment and access to Personal Identifiable
Information (PID)
Current international legislation to protect personal
privacy (autonomy) restricts unconsented access to per-
sonally identifiable data (PID) [107]. This means that
researchers outside patients’ clinical care team (which
includes most qualitative investigators) cannot access
any personal information –including names, phone
numbers and addresses – without participant consent.
Legislation also contains enabling measures which allow
researcher access to PID where there is no practicable
alternative [10,19,45,49,108-111]. However, obtaining the
necessary permissions to utilise such measures involves
negotiating a complex, bureaucratic and lengthy applica-
tion process within regulatory systems that are highlyconservative and risk averse [9,19]. The prohibition on
researcher access to PID derives from legislation con-
cerning privacy rather than ethical principles. Neverthe-
less, within ethical review of research applications these
tend to be conflated, and there is no differentiation be-
tween the different kinds and related sensitivities of PID.
The restriction on unconsented access to any kind of
PID is reproduced as a formulaic imperative [10,19,45]
Invitations to take part in research are often made by
health professionals who would normally have access to
PID as direct providers of patient care. This may be re-
assuring for patients. However, in certain contexts, par-
ticularly those involving vulnerability and dependence
on critical care provided by clinicians who are also
undertaking the research in which the patient is invited
to participate, there is a risk of undue influence and co-
ercion [43,85]. Patients may likely feel much freer to re-
ject an invitation without compunction when it is made
by an unknown researcher to whom they feel no obliga-
tion or desire to please [85,112].
The restriction on access even to names and contact
details of prospective participants means that researchers
have to rely on health professionals to act as intermediar-
ies in making contact, even when these individuals are
not involved directly as investigators. Researchers then
have to wait for participants to respond, usually by mail,
to an indirect invitation from professional gatekeepers
[19,28,113]. The inefficiency of this unwieldy process of
requiring patients to opt in, rather than out, of studies
produces low rates of recruitment and jeopardises the
feasibility and successful outcome of qualitative research.
It also hands disproportionate influence over participant
selection to health care professionals who may them-
selves be subjects of investigation. The consequence of
prolonged and insufficient recruitment constitutes one of
the most frequent and serious challenges to the viability,
quality and effectiveness of difficult and costly research
[26]. It also undermines the capacity of study findings to
be applied directly for patient benefit [3,19,23].
Most of the current or planned reforms to streamline
research governance refer specifically to biomedical and
epidemiological research and make no reference to
qualitative studies. Clarification and revision of the
current restrictions on accessing PID for purposes of re-
spondent identification and recruitment should prove
helpful to all types of research. Beyond this, however, it
is not clear that the proposed reforms will progress a
wider awareness and acceptance of the contrasting eth-
ical paradigms which underpin biomedical and qualita-
tive studies.
Autonomy and informed consent
The primacy accorded to the abstract legal principle of
personal ‘autonomy’ within the bioethical framework
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sumerism) of Western industrial societies [45,50,114].
The social sciences offer very different understandings
of how individuals position themselves as decision-
makers and in relation to others. Decisions are made not
by autonomous agents but rather by actors embedded
within complex networks of social action and obligation
and with awareness of their assessment by, and conse-
quences for, others within both personal and wider so-
cial networks [29,42,115]. Bioethics is premised on the
research subject as a rational informed self and ignores
the relational component of decisions which are made in
consultation with, and in awareness of the interests of,
others [116]. This includes an assessment of the trust-
worthiness of science and the social value and benefits
of research as well as perceptions and appraisal of the
personal consequences of participation [43,85,89,94]. In-
formation provided in the Participant Information Sheet
may be understood in ways entirely different to those
the researcher intended [112,117]. The symbolic signifi-
cance of the ritual of informed consent as a cue to the
authority and trustworthiness of the researcher may be
of greater import than its ostensive significance as a val-
idation of participant understanding of the nature of the
study [118]. In practice, information plays a small, and
often negligible, part in most participant decisions to
take part in research. Such decisions may be impulsive,
heuristic and affective, and influenced less by rational
deliberation or neutral ‘information’ (however ‘full’) than
by discussion and negotiation [85,89,119]. As social
actors, individuals are mindful - and accepting – of their
obligations, as well as their entitlements. The ‘autono-
mous individual’ is an ideological construct: an ‘imagin-
ary’. The concept of autonomy may be instrumental
within legal, commercial and policy contexts, but it has
little salience as a social category. A more useful and ap-
propriate construct in this context is that of ‘agency’. In-
dividual interests are intertwined with those of others,
and realized through relationships of obligation and ex-
change. Consequently, the current preoccupation with
autonomy as a singular marker of ‘respect for persons’
and its pre-eminence among the four bioethical princi-
ples is unwarranted and calls for revision [50,85,120].
Within the bioethical paradigm, research participation
should be voluntary and based on fully informed con-
sent. However, in qualitative research transparency of
purpose and of method is not always easy to achieve.
This partly derives from the flexibility of qualitative re-
search and its goal of adapting and responding to situa-
tions and developments arising in real world settings
[83,121,122]. Many observational studies take place in
semi-public places (including the internet). It is not
practicable to control the movement of people entering
and leaving the field, or to ensure that everyone whodoes so has been adequately informed about the study
and given their consent [29,30,41,123]. Researchers sim-
ply do not have the control over the research field which
is predicated in formal ethical approval. The precise
focus of some qualitative studies may deliberately be
kept vague. This arises because success may depend on
keeping response bias to a minimum or to avoid causing
distress in cases where the study focus encompasses an
investigation of responses to experiences of diagnosis
and prognosis of which participants may be unaware.
Even within a single research interview, neither investi-
gator nor participant can fully anticipate the content or
outcome of the encounter, or what new topics and
insights may emerge. Consequently, it is hard to be
highly specific in giving information about the study, or
indicating precisely what research participants are sign-
ing up to [9,113]. As indicated above, qualitative re-
search engages with participants on the basis of ongoing,
process consent. This is tailored, negotiated and reaf-
firmed throughout the participant’s continuing participa-
tion and cooperation in the study. Especially with
participants from marginal, stigmatized or deviant popu-
lations the requirement for signed consent may be
experienced as unwelcome, inappropriate or even coer-
cive, and can impair the development of trust between
researcher and participants [9,28,30,85,102,124,125]. In-
deed, some people may judge that their interests - and
anonymity - are best served and protected by engaging
in research with literally ‘no strings attached’.
Confidentiality
The research enterprise depends on trust based on the
promise of confidentiality. This has traditionally been a
core commitment of qualitative research. It is a primary
means of protecting respondents from any adverse con-
sequences of research participation, and also a precondi-
tion of the meaningful exploration of many difficult and
sensitive areas of human activity and experience, espe-
cially involving marginal and stigmatized social groups
[9]. As indicated above, ‘non-maleficence’ is an under-
pinning principle of research conduct: participants
should not be harmed through taking part in research.
Confidentiality is particularly important when the ano-
nymity of participants cannot always be guaranteed, for
example where research involves small or unusual sam-
ples, identifiable locations, or ‘elite’ respondents with
local or national profiles [9,46,126]. This commitment
can give rise to controversial and uncomfortable situa-
tions beyond easy compromise or resolution. However,
the importance of maintaining trust as an underpinning
principle of service delivery is recognised in clinical
practice and public health, for example in relation to the
concealment of identity of doctors affected by HIV, or
HIV patients known to be engaging in unprotected sex
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commitments should be honoured in relation to re-
search participation. However, current practices relating
to professional ‘duty of care’ have become generalised
from health professionals undertaking health services re-
search to all researchers undertaking any kind of re-
search. In principle, and as stipulated in the British
Sociological Association and Association of Social
Anthropologists statements of ethical guidelines, confi-
dentiality of research participants should only be broken
in exceptional circumstances, where issues of public
interest are clearly raised [106,128]. In practice, and in
view of the uncertainties about current legislation and
risk aversion of regulatory bodies, a much more routine
and formulaic application has evolved [9,10,45,76,129].
These impose an obligation on researchers to break par-
ticipant confidentiality in the event that they reveal
(what is judged to be) evidence of illegal activity or actual
or potential harm to themselves or others [130-132]. The
routine requirement to offer participants only qualified
or partial confidentiality effectively undermines the basis
on which much research involving deviant or marginal
populations and sensitive topics may be successfully
undertaken. The nature and purpose of research should
not be confounded with the practice of health care. This
is not to say that circumstances may never arise where a
researcher feels that it is necessary to break confidential-
ity. The literature on how researchers have dealt with
such dilemmas in practice reveals the nature of ‘ethical’
decisions to be grounded in the particularity of contexts
and situations [129,130,133,134]. Researchers are clearly
not exempt from the obligation to observe legal and
regulatory requirements. However, the occurrence of eth-
ical dilemmas in the field calls for deliberative judgement
which can be informed and guided but not resolved by
normative procedural rules. Rather than resort to formu-
las and avoidance, there needs to be acknowledgement
and acceptance of the intrinsically difficult nature of eth-
ical issues. These do not lend themselves to easy or
sometimes even any satisfactory solution. In some situa-
tions there may not be, self-evidently or unequivocally, ‘a
right thing to do’. It may not be possible to support the
best interests of all participants. In these situations the
researcher can only make the best judgement she can,
informed by knowledge of the particular context (‘thick
ethical description’ [135]) and awareness of the ethical
principles and debates relating to each case. In practice,
at least within health services research, the occurrence of
situations in which breaching confidentiality becomes an
issue are extremely rare as, indeed, are other ‘hypotheti-
cals’ (e.g. the prospect of ‘harm’ resulting from qualita-
tive studies) which are nevertheless mandated for
inclusion in the standard information sheets supplied to
participants.Incapacity
The case is clear for relaxing the protectionist and pater-
nalistic stance of current regulatory processes in relation
to people taking part in qualitative studies where cap-
acity is not at issue. People can make their own deci-
sions about whether a researcher is trustworthy, if they
wish to participate, how they wish to engage in the study
and they can withdraw at will. Studies where this is not
the case are more problematic, e.g. those involving chil-
dren, persons with learning disabilities or cognitive im-
pairment. However, further knowledge is badly needed
to increase understanding and improve services and care
for such vulnerable and frequently under-researched
groups. Indeed, it has been argued that current restric-
tions applying to the inclusion of vulnerable subjects in
research constitute actual harm, rather than a benefit or
protection, on two counts. Firstly, such groups are de-
nied the benefits which research can confer. Second, in
being excluded from the opportunity to take part in re-
search, they are denied the chance to contribute as social
agents and to have a voice in the development of policies
and services relevant to their condition [4,42,49,100].
The bioethical principle of autonomy requires that re-
search participation should be voluntary, informed and
undertaken by persons with capacity to make independ-
ent decisions. This formally excludes all persons lacking
such capacity from involvement in research. To get
around this restriction, a utilitarian fudge can be brought
into play. Subject to favourable ethical review, persons
lacking capacity may be included in research on the
basis of consultation and advice either with a nominated
or designated proxy (often a relative) or, where these are
not available, an independent advocate [39,100,136,137].
The substituted judgement of such proxy agents may be
based on inaccurate or no prior knowledge of the patient
or his wishes. These could, in any case, be impossible to
determine. It is not usual for individuals to hold and
share clearly formulated anticipatory wishes about in-
volvement in research in the event of future incapacity.
Even where these are in place, it is a moot point how
well future preferences relating to a drastically altered
state of cognitive and functional capacity can be antici-
pated in advance [138]. Consequently, it is not readily
apparent how this aspect of the regulations governing
inclusion of persons lacking capacity in research serves
to protect ‘autonomy’.
In some studies the complex processes involved in
obtaining consultee opinions may not pose a problem.
In any case, where research involves interventions which
are intrusive or entail risk of actual harm, the interests
of vulnerable subjects must be safeguarded and partici-
pation subject to careful consideration and review. This
is the intent and appropriate purpose of current legisla-
tion and formal ethical review. In contrast, qualitative
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or harm to participants. However, research occurring in
naturalistic settings, particularly where observation is
involved, often simply cannot fit within the slow and
cumbersome pace of governance bureaucracy: the real
world moves too fast. The issue here is the extent to
which we are prepared to engage with the ethical dilem-
mas which may arise in carrying out qualitative research
and accept that these may not always be resolvable
within the current bioethical framework of research gov-
ernance. There is often not self- evidently a ‘right’ thing
to do, and the most that can be asked is that researchers
make the best judgement they can and also that such
judgements should be supported by discussion, reflec-
tion and knowledge, rather than subject to censure.
Within the bioethical framework, individual interests
trump those of science and society [45,136]. However, to
undertake meaningful qualitative research, a trade off
needs sometimes to be made in balancing the interests
of the individual against those of the group, the potential
intrusion of research against its benefits. This needs to
be acknowledged and accepted [19,45,139].
Ethical mindfulness and the deskilling of researchers
Current governance places the qualitative researcher in
an invidious position, caught between formal require-
ments of ethical approval which do not incorporate any
understanding of the pragmatics of field work or the
concerns and interests of participants on the ground,
and the - equally ‘ethical’ - requirement to maximize
the scarce opportunity to deliver best quality research
with findings that may offer real impact and benefit to
patient care. The standard formulas and oversimplified
rules prescribed for research conduct appear to offer
solutions whilst eliding the real issues, from the quotid-
ian to the exceptional, to be encountered in real world
research. Far from promoting ethical research it has
been argued that the rigidity of procedural ethics is des-
killing. Rather than encouraging ethical discussion and
deliberation - the development of ‘ethical mindfulness’
- procedural codes and regulations merely serve to
undercut the researcher’s integrity and judgement
[5,16,18,22,28,44,140].
On the ground immediate judgements must often be
made about unanticipated events and opportunities
which fall outside the formal specification of how a
study should be conducted [141]. For example: research-
ers may inadvertently be presented with personal identi-
fiable data that they are supposed not to access without
prior consent. They may have to choose between fore-
going an opportunity to obtain data when a respondent
volunteers their willingness and availability to conduct
an on the spot interview, and adhering to the protocol
regarding ‘informed consent’ which requires advancenotification and reflection. In observational studies, staff
may omit to provide potential respondents with infor-
mation about the study. The researcher must choose
whether it is better to provide this directly to ensure that
the information is supplied, or observe the requirement
that researchers should not make direct initial contact
with participants. In practice it may be impossible to en-
sure that information has been distributed to patients
during admission to a ward. It can be hard to know in
advance how many respondents should be recruited. If
the specified target is substantially exceeded, or it
emerges that representation from different groups is
required, data collection must be paused or disrupted
pending further approvals of protocol amendments by
the REC and NHS research and development depart-
ments. This process usually takes several months, with
adverse knock on consequences for the completion of
the study within schedule. Meanwhile the chance to in-
clude specific individuals or groups may have passed,
and the opportunity lost. People may offer their partici-
pation and cooperation but on their own terms. For ex-
ample, they may not want to sign consent, or may be
willing to talk on the spot but not to arrange a formal
meeting in the future. During a scheduled interview in a
respondent’s house, a spouse or other person may unex-
pectedly join in the discussion. The researcher cannot
know in advance if they are going to make a brief or
more substantial contribution to the interview. Nor can
she request that they should leave the room. Gradually,
it emerges that the discussion has turned into a joint
interview. The researcher is then caught between the
formal - but in this case gratuitously disruptive - re-
quirement to go through the process of seeking written
consent and risk jeopardizing the interview by violating
the social rules of the encounter. Or she can make a
pragmatic judgement that both respondent and spouse
are comfortable with jointly engaging in the interview
and that the spouse’s consent is clearly indicated by his/
her participation in the discussion and any questions
about the research which commonly arise during and
(especially) after the interview. And so on [28,30,95].
In contrast to the formal procedures of bioethical
regulation, Pels [44] has called for a ‘morality of negoti-
ation’ and a recognition and tolerance of ‘emergent eth-
ics’ in qualitative research, composed contingently,
perhaps not always consistently, but pragmatically, and
appropriately for the situation in hand [9,44,104,142].
This shifts the focus away from formal processes of ex-
ternal regulation towards an increased reliance on - and
recognition of - the skill, training and trustworthiness of
individual researchers [18,129]. This approach fits well
with the emerging critique of bioethics offered by ‘em-
pirical ethics’. This seeks to remedy the shortcomings of
an overly abstract nature of bioethical principalism by
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bedded and resolved in real world experience and prac-
tice. Ethical deliberation would then be informed by an
understanding of how and why decisions are made in
specific contexts, rather than simply specifying a priori
rules for how they should be made. For example, in-
creasing evidence that the formal requirement that re-
search participation must be based on ‘informed
consent’ is largely unrealisable, and the presumption that
research proceeds on this basis is a fiction, should
prompt a reappraisal of the current ‘rules’ for negotiating
participation. Similarly, a true respect for, and operatio-
nalisation of, autonomy would start from an understand-
ing of how research participants understand and value
autonomy and modify governance requirements accord-
ingly [99,143-145]. This is not to say that research ethics
is then left rudderless on a sea of relativism and descrip-
tive subjectivity, nor that researchers should not be sub-
ject to scrutiny and supervision. But it is acknowledged
that failure to factor in the context and nature of real
world practice and experience results, according to Cor-
rigan’s characterisation, in merely ‘empty ethics’ [43].
Censoring research
The current difficulty in obtaining ethical approval for
qualitative studies of sensitive issues or involving vulner-
able populations discourages researchers from attempt-
ing to carry out such work. This constitutes a form of
censorship, limiting and directing the kinds of research
questions that may be asked and how they may be inves-
tigated [4,5,9,16,146,147]. In consequence, vulnerable pa-
tient groups are excluded from research and the voice
which this may give them to apply leverage in improving
care [49,148,149]. Misplaced protectionism on the part
of ethical committees in closing research to vulnerable
groups may constitute a harm rather than intended
benefit [4,42].
The conditions which apply to gaining access to per-
sonal identifiable data and the requirements for
informed consent impose complex constraints on acces-
sing and recruiting participants. Current legislation con-
tains enabling provisions for these restrictions to be
overcome in order that research may be undertaken. In
practice, however, the conservative and risk aversive cul-
ture of ethical review means that the procedures
required to obtain such permissions are complex and
protracted to the extent of deterring all but the most
determined researcher, and perhaps the few who have
unlimited time required to pursue the endeavour
[11,19,45,69]. The upshot is that qualitative researchers
(and others too, but it is qualitative research that I am
primarily concerned with here) have become burdened
with a system of ethical review that is cumbersome, in-
appropriate and restrictive to the point that it is makingresearch, particularly in relation to vulnerable popula-
tions and sensitive topics, increasingly hard and some-
times even impossible. The need for some form of
external regulation and ethical review is not contested,
but this should be proportionate to the risks involved
and conducted with sufficient expertise. The potential
harms of qualitative research should be acknowledged,
for example: intrusion into personal privacy, arousal of
distress, embarrassment, or breaches in confidentiality.
However, these are rare, relatively minor and commen-
surate with the normal vagaries of everyday life. The lit-
erature reveals no known or recorded instance of
complaint or harm, and suggests that many respondents
find research participation to be a positive experience
even when this involves discussion of topics that may be
difficult and distressing. Much research is no more in-
trusive or invasive of personal privacy than routine clin-
ical audit or service evaluation, but it is treated radically
differently [19]. This suggests that the function of
current governance arrangements is to control and dis-
cipline, rather than promote and enable, the research
effort [4,5,8,9].
Rebalancing beneficence autonomy and justice
Given the promotion of research as a core activity and
political priority within the health services of developed
nations [37,150-152] the widespread public acceptance
of research, and their willingness to participate in contri-
bution to a public good, it is reasonable to revise current
conventions which routinely assign autonomy pre-
eminence over other ethical principles. Perhaps it is time
to move the bar a little more towards the ‘community’
rather than the ‘individual’ end of the interests spectrum,
from the current privileging of ‘autonomy’ towards
a greater emphasis on ‘beneficence’ and ‘justice’
[19,45,49,139,153,154]. Patients who benefit from treat-
ment within the NHS or other health care systems can
expect to find research being carried on as a routine ac-
tivity, and that it is reasonable to be approached with an
invitation to participate, perhaps even to presume ac-
ceptance rather than rejection, at least in relation to
non-intervention research involving minimal risk
[19,45,49,153]. This is, of course, always on the under-
standing that participation is voluntary and can be read-
ily withdrawn. Accredited researchers working on
approved studies and bound by the same standards of
confidentiality as clinicians could (as formerly) be per-
mitted access to patient data to the extent that this is
required to conduct their research [75]. It is reasonable
to propose that in relation at least to non-invasive re-
search (qualitative and health service studies) a shift
from in principle opt in to opt out from research would
be acceptable. In addition, patients could be asked to in-
dicate their willingness to be approached about research
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Such changes depend on public acceptance and support,
and much further involvement of the public in discus-
sion and debate about the social value of research and
how it should be conducted is required [10,19,154].
Summary and conclusion
Ethical regulation has become increasingly complex and
restrictive without any evidence that the current ma-
chinery has improved the quality of qualitative research
or protected research participants from substantive
harm. However, it is clear that qualitative research does
not fit within the current bioethical framework of ethical
regulation which was designed to protect research parti-
cipants from the very real harms which could be
involved in taking part in experimental studies including
commercial drugs trials. The need for ethical review and
regulation is not at issue. However, this must be appro-
priate and proportionate to the risks involved. Existing
regulatory frameworks disenfranchise qualitative research-
ers by preventing them from carrying out flexible, respon-
sive research according to accepted best practice within
their academic disciplines. They force adherence to a bur-
eaucratic system of procedural ethics which is ill suited to
the nature of the research and which, in the worst case,
works ‘unethically’ to compromise the quality and reach –
and consequently also the value - of the findings. The
greatest protection for participants in qualitative studies is
for adequately skilled and experienced researchers to con-
duct and supervise research. Researchers should, of
course, be accountable for their actions and work within
institutional systems of supervision and support. However,
moving responsibility from an over-reliance on external
audit towards a greater degree of internal accreditation
and review would exert powerful leverage in increasing
the quality and integrity of qualitative research.
The rule-based procedural ethics which dominates
current regulatory structures is fundamentally at odds
with the practice of emergent and continually negotiated
processes of ‘micro ethics’ required to undertake qualita-
tive research which is both feasible and maintains integ-
rity. The complex and shifting nature of real world
settings (occasionally) deliver substantial ethical issues
which may not lend themselves to easy resolution, but
this is the exception, rather than the norm. Procedural
ethics cannot address the specific ethical dilemmas that
arise in the real world settings of qualitative investiga-
tion. This is not to say that qualitative studies are ‘un-
ethical’, but that their ethical conduct cannot be
safeguarded by adherence to a rigidly pre-determined
protocol. Rather, such safeguarding depends on the exer-
cise of ongoing judgement and personal integrity of
researchers in the field. Bioethics prioritises procedures
and formulas (giving out information, obtaining a signedconsent form) over process (the quality of the discussion
about the research, establishing the degree of partici-
pants’ understanding and willingness to take part).
Qualitative studies need to be evaluated within a differ-
ent set of criteria than that which is applied within the
bioethical framework which dominates current systems
of ethical review and by reviewers who have a proper
understanding of the methodologies to be employed and
the realities of conducting sensitive research in naturalis-
tic settings. Empirical ethics is proposed as an approach
to counteract the abstract formalism of procedural bio-
ethics, and improve the relevance and quality of research
governance through an understanding of the context of
participants’ decision making in real world settings, and
the values and reasoning underpinning these. It is to be
hoped that current national and international proposals
to streamline processes of ethical review will expedite
these changes and stimulate a review and clarification of
current legislation. There is also a need to actively en-
gage the public in dialogue about the role and value of
research and how they may be willing to support this as
a collective social endeavour. If the public is to benefit
from research then it is incumbent that the effort and
resources invested – especially in difficult and sensitive
areas of investigation – are used to best effect. Indeed,
clear ethical issues are involved in failing to do so.Endnotes
aIn the UK, this includes the Mental Capacity Act,
2005; Data Protection Act, 1998, Freedom of Informa-
tion Act, 2000 and Health and Social Care Act, 2001.
Internationally, such protective legislation has become
widespread, e.g. European Data Protection Directive
(1995), Clinical Trials Directive, 2001, NIST Guide to
Protecting the Confidentiality of Personally Identifiable
Information (USA), Privacy Act, 1988 (Australia), Privacy
Act, 1983 (Canada).
bThe Advance Notice of Proposed Rulemaking
(ANPRM) under consideration in the US is unusual in
proposing changes based on assessment of risk and pro-
portionality which, if implemented, should prove highly
enabling for qualitative research 12. Emanuel EJ, Menik-
off J: Reforming the Regulations Governing Research with
Human Subjects. New England Journal of Medicine 2011,
365:1145–1150, 40. Human Subject Research Protec-
tions: Enhancing Protections for Research Subjects and
Reducing Burden, Delay, and Ambiguity for Investigators,
FAQs [http://www.hhs.gov/ohrp/index.html; http://www.
hhs.gov/ohrp/humansubjects/anprmqanda.html/].
cThe bioethical framework underpinning research gov-
ernance also causes problems for researchers engaged in
biomedical and other kinds of research, but consider-
ation of these is outside the scope of the present paper.
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